PVH
6.10.2020 18:02:13 CEST | Business Wire | Press release
PVH Europe, the global headquarters of Tommy Hilfiger and the European offices of Calvin Klein, both owned by PVH Corp. [NYSE: PVH], announces the installation of what is believed to be the world’s most powerful* currently operational solar roof at its state-of-the-art Warehouse and Logistics Center in Venlo, the Netherlands. Generated by more than 48,000 solar panels, the solar roof covers the Center’s electricity footprint, as well as indirectly providing 100% of all energy for PVH Europe’s warehouses, offices and stores in the Netherlands via the Dutch public power network. PVH Europe’s energy partner, Eneco, has certified that all energy needed to power these buildings is generated by the new rooftop installation. The Venlo Warehouse and Logistics Center is owned by Heylen Warehouses, a Belgian logistics real estate company, in a joint venture with AG Real Estate, and retained IZEN as the technical installation partner for the roof.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201006005513/en/
This milestone marks another step in PVH’s journey to procure 100% of its electricity from renewable sources for its offices, warehouses and stores, and to drive a 30% reduction in supply chain carbon emissions by 2030. This work is linked to PVH’s science-based emissions target aligned with the most ambitious level of decarbonization as set out by the Paris Agreement. It is also one of the priorities outlined in the company’s Forward Fashion corporate responsibility strategy, which aims to reduce negative impacts to zero, increase positive impacts to 100% and improve the over 1 million lives across the company’s value chain.
Key Facts:
- The Venlo warehouse is PVH Europe’s main distribution center covering 110,000m2 .
- Awarded a BREEAM (Building Research Establishment Environmental Assessment Method) sustainability rating of “Very Good”.
- The world’s most powerful solar roof, with a capacity to generate 18 MWp (megawatt peak).
- Facilitated by over 48,000 high performance solar panels.
- Fully powers all PVH Europe owned stores, warehouses and offices in the Netherlands.
“This is an incredible milestone for our Warehouse and Logistics Center in Venlo and for PVH Europe’s sustainability journey,” said Martijn Hagman, CEO ,Tommy Hilfiger Global and PVH Europe. “We have participated in the installation of what we believe is now the world’s most powerful, fully operational solar roof – a huge stride in our commitment to be powered by 100% renewable electricity by 2030 and reduce supply chain emissions by 30% by 2030. This would not have been possible without a best-in-class team of such talented, passionate, and devoted PVH associates.”
At present, up to 600,000 pieces of TOMMY HILFIGER and CALVIN KLEIN product are distributed daily from the PVH Europe Warehouse and Logistics Center in Venlo to points of sale, including owned and operated stores in Europe, the Middle East and Africa, and direct to customers. The warehouse’s Very Good rating by BREEAM incorporates exemplary standards for energy, water, transport, materials, waste, pollution, ecology, health and well-being. This is reflected through energy efficient lighting in 100% of the space, the use of 100% FSC (Forest Stewardship Council) certified packaging and 100% recycling of all cardboard, plastics and printed material.
PVH is a member of RE100, the corporate renewable electricity initiative led by the Climate Group, and has committed to RE100 to procure 100% of its electricity from renewable sources by 2030.
Sam Kimmins, Head of RE100 at the Climate Group said: “Congratulations to PVH on the finalization of the Venlo solar rooftop. This is another exciting step in their global work and partnership towards their 2025 RE100 target. It raises the bar once more for on-site renewables.”
“ We believe that logistic buildings will be the next generation of solar power plants,” said Philippe Deschilder, CEO of Heylen Warehouses. “The partnership with PVH Europe for the solar roof project supports our ambition to invest in renewable energy, creating added value for our customers by enabling them to reduce their carbon footprint.”
About PVH Corp.
PVH is one of the most admired fashion and lifestyle companies in the world. We power brands that drive fashion forward – for good. Our brand portfolio includes the iconic CALVIN KLEIN , TOMMY HILFIGER , Van Heusen , IZOD , ARROW, Warner’s , Olga and Geoffrey Beene brands, as well as the digital-centric True&Co. intimates brand. We market a variety of goods under these and other nationally and internationally known owned and licensed brands. PVH has over 40,000 associates operating in over 40 countries and $9.9 billion in annual revenues. That's the Power of Us. That’s the Power of PVH.
Follow us on Facebook , Instagram , Twitter and LinkedIn .
About RE100
RE100 is a global initiative bringing together the world’s most influential businesses committed to 100% renewable power. Led by the Climate Group in partnership with CDP , the group has a total revenue of over US$5.4 trillion and operates in a diverse range of sectors. Together, they send a powerful signal to policymakers and investors to accelerate the transition to a clean economy. #RE100
*PVH defines the “world’s most powerful solar roof” as the most powerful solar roof that is currently operational and installed on one singular structure.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201006005513/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom